Objective: To determine whether serum vitamin D levels had a relationship with pulmonary function test (PFT) results and serum immunoglobulin E (IgE) levels in allergic patients with and without asthma. Method: The study group was comprised of patients who had positive allergy skin tests with and without asthma (n=31, n=28, respectively) and healthy controls (n=31). The skin allergy test (prick test) and PFT were performed on all of the study groups. Also, the patients’ serum vitamin D and IgE levels were determined. Comparisons among these groups and also subgroups of the patients were investigated in addition to correlation analyses for vitamin D, IgE and PFT results. Results: Seventy percent of the asthma group was found to have abnormal PFT results, while all healthy controls and non-asthmatic patients had normal PFT results (p
Amaç: Astım tanısı olan ve olmayan alerjik hastalarda D vitamini düzeylerinin solunum fonksiyon testi (SFT) sonuçları ve serum immünoglobulin E (IgE) düzeyleri ile ilişkisinin belirlenmesi amaçlandı. Yöntem: Çalışma grubu, alerjik cilt testi pozitif olan astımı olan ve olmayan hastalardan (sırasıyla n=31, n=28) ve sağlıklı kontrollerden (n=31) oluşuyordu. Tüm çalışma grubuna cilt alerji testi (prick testi) ve SFT uygulandı. Ayrıca, hastaların serum vitamin D ve IgE seviyeleri belirlendi. Vitamin D, IgE ve SFT sonuçları arasındaki korelasyon analizlerine ek olarak bu gruplar ve hasta alt grupları arasında karşılaştırmalar yapıldı. Bulgular: Astım grubunun %70’inde anormal SFT sonuçları saptanırken, tüm sağlıklı kontroller ve astımlı olmayan hastalar normal SFT sonuçlarına sahipti (p
1. Mims JW, (editor) Asthma: definitions and pathophysiology. International forum of allergy & rhinology. 2015: Wiley Online Library.
2. Masoli M, Fabian D, Holt S, Beasley R, Program GIfA. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy. 2004;59:469-478.
3. National Asthma Education and Prevention Program. Prevention P. Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007. The Journal of allergy and clinical immunology 2007;120(5 Suppl):S94.
4. Turkeli A, Ayaz O, Uncu A, Ozhan B, Bas V, Tufan A, et al. Effects of vitamin D levels on asthma control and severity in pre-school children. Eur Rev Med Pharmacol Sci 2016;20:26-36.
5. Tamašauskienė L, Gasiūnienė E, Lavinskienė S, Sakalauskas R, Šitkauskienė B. Evaluation of vitamin D levels in allergic and nonallergic asthma. Medicina 2015;51:321-327.
6. Palmer MT, Lee YK, Maynard CL, Oliver JR, Bikle DD, Jetten AM, et al. Lineage-specific effects of 1, 25-dihydroxyvitamin D3 on the development of effector CD4 T cells. Journal of Biological Chemistry 2011;286:997-1004.
7. Muehleisen B, Gallo RL. Vitamin D in allergic disease: shedding light on a complex problem. Journal of Allergy and Clinical Immunology 2013;131:324-329.
8. Ginde AA, Mansbach JM, Camargo CA. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Archives of internal medicine 2009;169:384-390.
9. Shahin MYA, El-Lawah AA, Amin A, El-Tawil IA. Study of serum vitamin D level in adult patients with bronchial asthma. Egyptian Journal of Chest Diseases and Tuberculosis 2017;66:5-9.
10. Maalmi H, Berraïes A, Tangour E, Ammar J, Abid H, Hamzaoui K, et al. The impact of vitamin D deficiency on immune T cells in asthmatic children: a case-control study. Journal of asthma and allergy 2012;5:11-19.
11. Urry Z, Chambers ES, Xystrakis E, Dimeloe S, Richards DF, Gabryšová L, et al. The role of 1 , 25 dihydroxyvitamin D3 and cytokines in the promotion of distinct Foxp3+ and IL 10+ CD4+ T cells. European journal of immunology 2012;42:2697-708.
12. Wolterink KRG, KleinJan A, van Nimwegen M, Bergen I, de Bruijn M, Levani Y, et al. Pulmonary innate lymphoid cells are major producers of IL 5 and IL 13 in murine models of allergic asthma. European journal of immunology 2012;42:1106-1116.
13. Iqbal SF, Freishtat RJ. Mechanism of action of vitamin D in the asthmatic lung. Journal of Investigative Medicine 2011;59:1200- 1202.
14. Wittke A, Chang A, Froicu M, Harandi OF, Weaver V, August A, et al. Vitamin D receptor expression by the lung micro-environment is required for maximal induction of lung inflammation. Archives of biochemistry and biophysics 2007;460:306-313.
15. Brehm JM, Schuemann B, Fuhlbrigge AL, Hollis BW, Strunk RC, Zeiger RS, et al. Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study. Journal of Allergy and Clinical Immunology 2010;126:52-8. e5.
16. Niruban SJ, Alagiakrishnan K, Beach J, Senthilselvan A. Association between vitamin D and respiratory outcomes in Canadian adolescents and adults. Journal of Asthma 2015;52:653-661.
17. Li F, Peng M, Jiang L, Sun Q, Zhang K, Lian F, et al. Vitamin D deficiency is associated with decreased lung function in Chinese adults with asthma. Respiration 2011;81:469-475.
18. Brehm JM, Celedón JC, Soto-Quiros ME, Avila L, Hunninghake GM, Forno E, et al. Serum vitamin D levels and markers of severity of childhood asthma in Costa Rica. American journal of respiratory and critical care medicine 2009;179:765-771.
19. Ma X, Zhen Y. Serum levels of 25-(OH) D (3) and total IgE in children with asthma. Zhongguo dang dai er ke za zhi=Chinese journal of contemporary pediatrics 2011;13:551-553.
20. Sharief S, Jariwala S, Kumar J, Muntner P, Melamed ML. Vitamin D levels and food and environmental allergies in the United States: results from the National Health and Nutrition Examination Survey 2005-2006. Journal of Allergy and Clinical Immunology 2011;127:1195-1202.
21. Tolppanen AM, Sayers A, Granell R, Fraser WD, Henderson J, Lawlor DA. Prospective association of 25-hydroxyvitamin d3 and d2 with childhood lung function, asthma, wheezing, and flexural dermatitis. Epidemiology 2013;24:310-319.
22. Damera G, Fogle HW, Goncharova EA, Zhao H, Banerjee A, Tliba O, et al. Vitamin D inhibits growth of human airway smooth muscle cells through growth factor-induced phosphorylation of retinoblastoma protein and checkpoint kinase 1. Br J Pharmacol 2009;158:1429-1441.